Foxo3a drives proliferation in anaplastic thyroid carcinoma via transcriptional regulation of cyclin A1: A paradigm shift that impacts current therapeutic strategies
- 1 January 2012
- journal article
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 125 (18) , 4253-4263
Abstract
Summary The Forkhead transcription factor, FoxO3a, is a known suppressor of primary tumor growth through transcriptional regulation of key genes regulating cell cycle arrest and apoptosis. In many types of cancer, in response to growth factor signaling, FoxO3a is phosphorylated by Akt, resulting in its exclusion from the nucleus. Here we show that FoxO3a remains nuclear in anaplastic thyroid carcinoma (ATC). This correlates with lack of Akt phosphorylation at serine473 in ATC cell lines and tissues of ATC patients, providing a potential explanation for nuclear FoxO3a. Mechanistically, nuclear FoxO3a promotes cell cycle progression by transcriptional upregulation of cyclin A1, promoting proliferation of human ATC cells. Silencing FoxO3a with a reverse genetics approach leads to downregulation of CCNA1 mRNA and protein. These combined data suggest an entirely novel function for FoxO3a in ATC promotion by enhancing cell cycle progression and tumor growth through transcriptional upregulation of cyclin A1. This is clinically relevant since we detected highly elevated CCNA1 mRNA and protein levels in tumor tissues of ATC patients. Our data indicate therapeutic inactivation of FoxO3a may lead to attenuation of tumor expansion in ATC. This new paradigm also suggests caution in relation to current dogma focused upon reactivation of FoxO3a as a therapeutic strategy against cancers harboring active PI3-K and Akt signaling pathways.Keywords
This publication has 46 references indexed in Scilit:
- Deregulation of FOXO3A during prostate cancer progressionInternational Journal of Oncology, 2009
- Anaplastic thyroid cancer: molecular pathogenesis and emerging therapiesEndocrine-Related Cancer, 2009
- FOXO3a: a novel player in thyroid carcinogenesis?Endocrine-Related Cancer, 2009
- A New Fork for Clinical Application: Targeting Forkhead Transcription Factors in CancerClinical Cancer Research, 2009
- Distinct properties of cyclin-dependent kinase complexes containing cyclin A1 and cyclin A2Biochemical and Biophysical Research Communications, 2008
- Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and MisidentificationThe Journal of Clinical Endocrinology & Metabolism, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- FOXOs, cancer and regulation of apoptosisOncogene, 2008
- Phosphatidylinositol 3-Kinase/Akt and Ras/Raf-Mitogen-Activated Protein Kinase Pathway Mutations in Anaplastic Thyroid CancerThe Journal of Clinical Endocrinology & Metabolism, 2008
- Dynamic FoxO transcription factorsJournal of Cell Science, 2007